Genus plc (GENSY)
OTCMKTS · Delayed Price · Currency is USD
24.34
+1.34 (5.83%)
At close: Apr 11, 2025
Genus Market Cap
Genus has a market cap or net worth of $2.25 billion as of September 16, 2025. Its market cap has increased by 44.81% in one year.
Market Cap
2.25B
Enterprise Value
2.55B
Revenue
921.77M
Ranking
n/a
PE Ratio
85.10
Stock Price
$24.34
Market Cap Chart
Since January 30, 1998, Genus's market cap has increased from 50.66M to 2.25B, an increase of 4,342.18%. That is a compound annual growth rate of 14.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2025 | 2.25B | 76.27% |
| Dec 31, 2024 | 1.27B | -29.66% |
| Dec 29, 2023 | 1.81B | -22.93% |
| Dec 30, 2022 | 2.35B | -46.03% |
| Dec 31, 2021 | 4.36B | 17.14% |
| Dec 31, 2020 | 3.72B | 36.75% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 789.71M |
| Tian'an Technology Group | 782.91M |
| Elite Pharmaceuticals | 735.19M |
| Glass House Brands | 548.40M |
| Northwest Biotherapeutics | 379.14M |
| American Oncology Network | 353.52M |
| CytoDyn | 351.92M |